Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.33
+0.12 (1.30%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Anavex Life Sciences Employees
Anavex Life Sciences had 42 employees as of September 30, 2024. The number of employees increased by 2 or 5.00% compared to the previous year.
Employees
42
Change (1Y)
2
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$1,106,929
Market Cap
793.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
AVXL News
- 19 hours ago - Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board - GlobeNewsWire
- 2 days ago - Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East - GlobeNewsWire
- 18 days ago - Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease - GlobeNewsWire
- 23 days ago - Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 2 months ago - Anavex: Looking At Different Statistical Approaches Before EMA Opinion - Seeking Alpha
- 2 months ago - Anavex: Further Validation Of Blarcamesine With Schizophrenia Data In 2025 - Seeking Alpha
- 2 months ago - Anavex Life Sciences Corp. (AVXL) Q1 2025 Earnings Call Transcript - Seeking Alpha